[
    {
        "text": "This episode of SciShow is brought to you\nby",
        "start": 0.11,
        "duration": 1.719
    },
    {
        "text": "the American Society of Gene and Cell Therapy.",
        "start": 1.829,
        "duration": 3.271
    },
    {
        "text": "[♩INTRO]",
        "start": 5.1,
        "duration": 3.02
    },
    {
        "text": "Lots of genetic diseases come down to a small\nchange to a single gene.",
        "start": 8.3,
        "duration": 4.799
    },
    {
        "text": "So you’d think that with genetic engineering,\nwe’d be able to treat",
        "start": 13.099,
        "duration": 2.96
    },
    {
        "text": "or even cure these diseases, an idea known\nas gene therapy.",
        "start": 16.059,
        "duration": 4.371
    },
    {
        "text": "The concept has a lot of potential, and there\nare already a few successful",
        "start": 20.43,
        "duration": 3.36
    },
    {
        "text": "treatments on the market, including one for\nan inherited disease.",
        "start": 23.79,
        "duration": 3.93
    },
    {
        "text": "But modifying genetic code also carries a\nlot of risks, so it’s been slow going.",
        "start": 27.72,
        "duration": 4.59
    },
    {
        "text": "And what happened, and is still happening,",
        "start": 32.31,
        "duration": 1.81
    },
    {
        "text": "with treatments for sickle cell disease is\na good example of both the challenges",
        "start": 34.12,
        "duration": 4.16
    },
    {
        "text": "that come from gene therapy",
        "start": 38.28,
        "duration": 1.58
    },
    {
        "text": "and the unexpectedly helpful discoveries that\ncan come from addressing them.",
        "start": 39.86,
        "duration": 4.6
    },
    {
        "text": "Sickle cell disease is the most common inherited\nblood disorder,",
        "start": 44.46,
        "duration": 3.619
    },
    {
        "text": "with more than 100,000 patients in the US\nalone.",
        "start": 48.079,
        "duration": 3.161
    },
    {
        "text": "People with sickle cell have red blood cells\nshaped like crescents, or sickles,",
        "start": 51.24,
        "duration": 4.35
    },
    {
        "text": "which would be enough of a problem on its\nown.",
        "start": 55.59,
        "duration": 2.23
    },
    {
        "text": "But their red blood cells also don’t carry\noxygen as well as the usual round ones.",
        "start": 57.82,
        "duration": 5.16
    },
    {
        "text": "The symptoms range from fatigue and jaundice",
        "start": 62.98,
        "duration": 2.58
    },
    {
        "text": "to bouts of excruciating pain when the curved\ncells jam up blood vessels.",
        "start": 65.56,
        "duration": 4.41
    },
    {
        "text": "In 1949, doctors realized the shape and problems\nwith carrying oxygen",
        "start": 69.97,
        "duration": 4.95
    },
    {
        "text": "are caused by a structural change to hemoglobin,",
        "start": 74.92,
        "duration": 3.05
    },
    {
        "text": "the molecule that carries oxygen around in\nhuman blood.",
        "start": 77.97,
        "duration": 2.26
    },
    {
        "text": "It wasn’t long before scientists had traced\nthe variation to specific changes",
        "start": 80.23,
        "duration": 4.04
    },
    {
        "text": "to hemoglobin genes, especially in the gene\nfor beta-globin,",
        "start": 84.27,
        "duration": 4.17
    },
    {
        "text": "one of the main protein parts of the hemoglobin\nmolecule.",
        "start": 88.44,
        "duration": 2.73
    },
    {
        "text": "But despite decades of work,",
        "start": 91.17,
        "duration": 1.51
    },
    {
        "text": "we still don’t have an approved gene therapy\nfor sickle cell disease.",
        "start": 92.68,
        "duration": 4.15
    },
    {
        "text": "Red blood cells don’t contain DNA and are\nonly alive for about 4 months before",
        "start": 96.83,
        "duration": 4.7
    },
    {
        "text": "they’re broken down and recycled by the\nbody, so to fix red blood cells,",
        "start": 101.53,
        "duration": 4.519
    },
    {
        "text": "you need to fix the cells that produce them:\nstem cells that live in bone marrow.",
        "start": 106.049,
        "duration": 4.641
    },
    {
        "text": "Researchers are working on a few different\napproaches to this.",
        "start": 110.69,
        "duration": 2.19
    },
    {
        "text": "The first method is simply adding working\nbeta-globin genes to bone marrow cells.",
        "start": 112.88,
        "duration": 4.279
    },
    {
        "text": "The red blood cells still carry some of the\nproblematic proteins;",
        "start": 117.159,
        "duration": 3.761
    },
    {
        "text": "they just also have enough healthy protein",
        "start": 120.92,
        "duration": 2.3
    },
    {
        "text": "to reduce the degree of sickling and improve\nsymptoms.",
        "start": 123.22,
        "duration": 3.09
    },
    {
        "text": "It’s the most straightforward treatment,",
        "start": 126.31,
        "duration": 1.919
    },
    {
        "text": "and there have already been multiple human\nclinical trials.",
        "start": 128.229,
        "duration": 2.971
    },
    {
        "text": "But it relies on repurposed viruses, modified\nto make sure they can’t cause disease,",
        "start": 131.2,
        "duration": 5.3
    },
    {
        "text": "to insert the desired DNA into the cells,\nwhich has turned out to be tricky.",
        "start": 136.5,
        "duration": 4.56
    },
    {
        "text": "A lot of viruses can’t infect bone marrow\ncells,",
        "start": 141.06,
        "duration": 3.13
    },
    {
        "text": "so scientists developed the technique using\na type known as lentiviruses.",
        "start": 144.19,
        "duration": 3.84
    },
    {
        "text": "Unfortunately, these viruses can put their\nDNA in lots of places,",
        "start": 148.03,
        "duration": 3.86
    },
    {
        "text": "which means the inserted genes can accidentally\nturn on or off",
        "start": 151.89,
        "duration": 3.459
    },
    {
        "text": "other important genes, including ones involved\nin regulating cancers.",
        "start": 155.349,
        "duration": 3.771
    },
    {
        "text": "And in the early 2000s, a ten-patient trial\nto fix an inherited immune disorder",
        "start": 159.12,
        "duration": 5.05
    },
    {
        "text": "had to be stopped early when two of the ten\npatients developed leukemia.",
        "start": 164.17,
        "duration": 3.99
    },
    {
        "text": "The researchers figured out what caused it\nand were able to treat both cases,",
        "start": 168.16,
        "duration": 3.53
    },
    {
        "text": "but newer designs are a lot safer.",
        "start": 171.69,
        "duration": 2.07
    },
    {
        "text": "The viral genes have been stripped to only\nones absolutely essential",
        "start": 173.76,
        "duration": 3.82
    },
    {
        "text": "for inserting DNA, so there are fewer genes\naround that might make them",
        "start": 177.58,
        "duration": 3.73
    },
    {
        "text": "more likely to insert the genes where they\ndon’t belong.",
        "start": 181.31,
        "duration": 2.89
    },
    {
        "text": "Plus, the viruses self-destruct after they\ndo their job to make sure",
        "start": 184.2,
        "duration": 3.56
    },
    {
        "text": "they don’t accidentally start replicating\nand causing problems,",
        "start": 187.76,
        "duration": 3.11
    },
    {
        "text": "like the viruses they’re based on.",
        "start": 190.87,
        "duration": 1.52
    },
    {
        "text": "There are still some concerns about effectiveness\nand side effects, though,",
        "start": 192.39,
        "duration": 3.929
    },
    {
        "text": "for example, it’s hard to be completely,\n100% sure",
        "start": 196.319,
        "duration": 3.181
    },
    {
        "text": "that the place where you put the extra DNA\nwon’t interfere",
        "start": 199.5,
        "duration": 3.349
    },
    {
        "text": "with the cell’s genome in a way that could\nlead to cancer.",
        "start": 202.849,
        "duration": 2.811
    },
    {
        "text": "That’s why other researchers are trying\nto edit the cell’s beta-globin gene",
        "start": 205.66,
        "duration": 3.92
    },
    {
        "text": "directly, replacing the disease-causing DNA\nwith a working sequence.",
        "start": 209.58,
        "duration": 4.799
    },
    {
        "text": "Editing a gene rather than adding a new one\ntends to be very effective,",
        "start": 214.379,
        "duration": 3.991
    },
    {
        "text": "but without the same risk of side effects\nbecause you know exactly where",
        "start": 218.37,
        "duration": 3.649
    },
    {
        "text": "the new information is going, where the old\none was.",
        "start": 222.019,
        "duration": 3.151
    },
    {
        "text": "You’re not trying to find somewhere to stick\nin a new one.",
        "start": 225.17,
        "duration": 2.88
    },
    {
        "text": "In one 2016 study, for example, researchers\nsuccessfully edited",
        "start": 228.05,
        "duration": 3.83
    },
    {
        "text": "the beta-globin genes in 90% of the human\nmarrow cells they tested.",
        "start": 231.88,
        "duration": 4.23
    },
    {
        "text": "But when they moved on to animal trials,",
        "start": 236.11,
        "duration": 1.5
    },
    {
        "text": "only 10% of cells actually survived and were\nincorporated into bone marrow.",
        "start": 237.61,
        "duration": 4.23
    },
    {
        "text": "So, something about the editing process either\nmakes the cells less viable,",
        "start": 241.84,
        "duration": 3.71
    },
    {
        "text": "or the immune system recognizes the foreign\nDNA somehow and kills them off.",
        "start": 245.55,
        "duration": 5.12
    },
    {
        "text": "Researchers are working out these kinks, though,",
        "start": 250.67,
        "duration": 1.629
    },
    {
        "text": "and this kind of editing technique is close\nto ready for human trials.",
        "start": 252.299,
        "duration": 3.531
    },
    {
        "text": "But there’s another way to treat sickle\ncell with gene editing,",
        "start": 255.83,
        "duration": 2.989
    },
    {
        "text": "and it might be the one that ultimately wins\nthe race:",
        "start": 258.819,
        "duration": 2.95
    },
    {
        "text": "getting cells to express a different protein\nthey already have.",
        "start": 261.769,
        "duration": 4.05
    },
    {
        "text": "During fetal development, we don’t actually\nmake hemoglobin using beta-globin.",
        "start": 265.819,
        "duration": 4.88
    },
    {
        "text": "We use a different protein, called gamma-globin,\ninstead.",
        "start": 270.699,
        "duration": 2.571
    },
    {
        "text": "And the gene for it never goes away,",
        "start": 273.27,
        "duration": 2.789
    },
    {
        "text": "it just gets turned off shortly after birth\nby regulatory genes,",
        "start": 276.059,
        "duration": 3.741
    },
    {
        "text": "which tell the cell to produce beta-globin\ninstead.",
        "start": 279.8,
        "duration": 2.85
    },
    {
        "text": "Doctors discovered that some people with sickle\ncell disease had fewer",
        "start": 282.65,
        "duration": 3.049
    },
    {
        "text": "symptoms because they never stopped producing\ngamma-globin.",
        "start": 285.699,
        "duration": 3.661
    },
    {
        "text": "And that gave them the idea that instead of\nusing beta-globin,",
        "start": 289.36,
        "duration": 3.529
    },
    {
        "text": "they could reactivate the gene for gamma-globin",
        "start": 292.889,
        "duration": 2.541
    },
    {
        "text": "by targeting one of the genes that regulates\nits expression.",
        "start": 295.43,
        "duration": 3.389
    },
    {
        "text": "It turns out that strategy might actually\nbe easier,",
        "start": 298.819,
        "duration": 2.88
    },
    {
        "text": "because it involves editing a gene to deactivate\nit rather than putting in new DNA.",
        "start": 301.699,
        "duration": 4.661
    },
    {
        "text": "And because of this, more of the cells seem\nto go back into the bone instead of dying.",
        "start": 306.36,
        "duration": 5.269
    },
    {
        "text": "Also, it’s not just a treatment for sickle\ncell,",
        "start": 311.629,
        "duration": 3.09
    },
    {
        "text": "several other blood disorders that are caused\nby issues with",
        "start": 314.719,
        "duration": 2.97
    },
    {
        "text": "the beta-globin gene could potentially be\ntreated by turning gamma-globin back on.",
        "start": 317.689,
        "duration": 4.691
    },
    {
        "text": "Like beta-thalassemia, for example, where\nerrors in the beta-globin gene",
        "start": 322.38,
        "duration": 4.119
    },
    {
        "text": "mean the person makes very little or no hemoglobin.",
        "start": 326.499,
        "duration": 2.88
    },
    {
        "text": "So far, animal studies have suggested the\ntechnique is really effective,",
        "start": 329.379,
        "duration": 4.44
    },
    {
        "text": "enough for human trials in patients with beta-thalassemia,",
        "start": 333.819,
        "duration": 3.38
    },
    {
        "text": "which started in Europe in 2018.",
        "start": 337.199,
        "duration": 1.53
    },
    {
        "text": "Of course, only time will tell which, if any,",
        "start": 338.729,
        "duration": 2.83
    },
    {
        "text": "of these gene therapies ends up becoming readily\navailable.",
        "start": 341.559,
        "duration": 2.57
    },
    {
        "text": "But with so many ways to get at the problem\nnearing or already in human trials,",
        "start": 344.129,
        "duration": 4.87
    },
    {
        "text": "researchers are hoping that something will\nprove effective in the near future.",
        "start": 348.999,
        "duration": 3.63
    },
    {
        "text": "And they've learned a lot",
        "start": 352.629,
        "duration": 1.0
    },
    {
        "text": "from all the challenges in developing a treatment\nfor sickle cell.",
        "start": 353.629,
        "duration": 2.531
    },
    {
        "text": "The challenges with engineering bone marrow\ncells and beta-globin genes has",
        "start": 356.16,
        "duration": 3.68
    },
    {
        "text": "led to all kinds of creative solutions,",
        "start": 359.84,
        "duration": 2.09
    },
    {
        "text": "like those lentiviruses and the new research\non gamma-globin.",
        "start": 361.93,
        "duration": 3.59
    },
    {
        "text": "Researchers might have set out to treat sickle\ncell disease, but in the process",
        "start": 365.52,
        "duration": 3.53
    },
    {
        "text": "they’ve made discoveries that could help\nwith all kinds of treatments.",
        "start": 369.05,
        "duration": 3.19
    },
    {
        "text": "Which hopefully means the future of gene therapy\ndevelopment",
        "start": 372.24,
        "duration": 2.62
    },
    {
        "text": "will go a little more smoothly in the future.",
        "start": 374.86,
        "duration": 2.1
    },
    {
        "text": "If you’re interested in following along\nwith that development,",
        "start": 376.96,
        "duration": 2.79
    },
    {
        "text": "or in learning more about the different types\nof gene therapy out there",
        "start": 379.75,
        "duration": 3.879
    },
    {
        "text": "and how they work, you should check out the\nnew patient education portal",
        "start": 383.629,
        "duration": 4.07
    },
    {
        "text": "from the American Society of Gene and Cell\nTherapy.",
        "start": 387.699,
        "duration": 3.06
    },
    {
        "text": "At SciShow, we are, of course, huge fans of\nfree online education,",
        "start": 390.759,
        "duration": 3.28
    },
    {
        "text": "and if you’re watching this, I’m guessing\nyou are, too.",
        "start": 394.039,
        "duration": 2.69
    },
    {
        "text": "The new portal is a super comprehensive resource\nfor everything gene and cell therapy:",
        "start": 396.729,
        "duration": 5.44
    },
    {
        "text": "there are clear explanations of the more fundamental\nideas,",
        "start": 402.169,
        "duration": 3.161
    },
    {
        "text": "along with fantastic summaries of past and\nongoing research",
        "start": 405.33,
        "duration": 3.449
    },
    {
        "text": "into different types of treatments.",
        "start": 408.779,
        "duration": 1.29
    },
    {
        "text": "To check it out for yourself, just head over\nto asgct.org/education,",
        "start": 410.069,
        "duration": 4.711
    },
    {
        "text": "or follow the link in the description below!",
        "start": 414.78,
        "duration": 2.3
    },
    {
        "text": "[♩OUTRO]",
        "start": 417.08,
        "duration": 10.06
    }
]